Evidence map›Paper›PMID 32792408›Full record

ArticleBMJ global health2020

The impact of country reimbursement programmes on living kidney donations.

Abu Bakkar Siddique, Vandana Apte, Sigrid Fry-Revere, Yanhong Jin, Naoru Koizumi

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Robotic versus laparoscopic versus open nephrectomy for live kidney donors.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Abu Bakkar SiddiqueSchar School of Policy and Government, George Mason University-Arlington Campus, Arlington, Virginia, USA anirbanju36@gmail.com.ORCID 0000-0002-9964-7511
Vandana ApteDepartment of Agricultural, Food and Resource Economics, Rutgers University, New Brunswick, New Jersey, USA.
Sigrid Fry-RevereIndependent Bioethics Scholar, Washington, District of Columbia, USA.
Yanhong JinDepartment of Agricultural, Food and Resource Economics, Rutgers University, New Brunswick, New Jersey, USA.
Naoru KoizumiSchar School of Policy and Government, George Mason University-Arlington Campus, Arlington, Virginia, USA.ORCID 0000-0001-8722-0898
George Mason University · USRutgers, The State University of New Jersey · USIndependent Sector · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLiving-donor kidney transplantation is the gold standard treatment for patients with end-stage kidney disease. However, potential donors ubiquitously face financial as well as logistical barriers. To remove these disincentives from living kidney donations, the governments of 23 countries have implemented reimbursement programmes that shift the burdens of non-medical costs from donors to the governments or private entities. However, scientific evidence for the effectiveness of these programmes is scarce. The present study investigates whether these reimbursement programmes designed to ease the financial and logistical barriers succeeded in increasing the number of living kidney donations at the country level. The study examined within-country variations in the timing of such reimbursement programmes.

methodThe study applied the difference-in-difference (two-way panel fixed-effect) technique on the Poisson distribution to estimate the effects of these reimbursement programmes on a 17 year long (2000-2016) dataset covering 109 countries where living donor kidney transplants were performed.

resultsThe results indicated that reimbursement programmes have a statistically significant positive effect. Overall, the model predicted that reimbursement programmes increased country-level donation numbers by a factor of 1.12-1.16.

conclusionReimbursement programmes may be an effective approach to alleviate the kidney shortage worldwide. Further analysis is warranted on the type of reimbursement programmes and the ethical dimension of each type of such programmes.

Indexed as

Kidney TransplantationLiving DonorsHumansKidneyhealth economicshealth policyother study design

Identifiers

PMID32792408
PMCPMC7430320
OpenAlexW3048937465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.